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Background: Although slow/no-reflow is a serious problem complicating primary percutaneous coronary interventions (PCI) for acute myocardial 
infarction (AMI) and is associated with a poor prognosis, its efficacious treatment remains problematic. We compared the acute, in-hospital and 
long-term (1 year) effects of nitroprusside (NTP) with those of nicorandil (NC) on the slow/no-reflow phenomenon.
Methods: Fifty-two of 482 consecutive patients with AMI who underwent primary PCI complicated by slow/no-reflow and who received intracoronary 
NTP (n=27) or NC (n=25) administration were studied.
Results: Both NTP and NC induced significant improvements in coronary flow, with increases in TIMI flow grade from 1.63±0.61 to 2.75±0.35 
(p<0.001) and 1.59±0.85 to 2.24±0.92 (p<0.001) and in corrected TIMI frame count from 37.6±15.0 to 13.8±7.2 (p<0.001) and 30.6±20.6 to 
19.4±17.8 (p<0.001), respectively. The degree of improvement in TIMI flow grade (post-pre/pre) and TIMI frame count (pre-post/pre) showed that 
NTP was more effective than NC (NTP vs NC: 0.89±0.78, 0.36±0.36, p=0.007; 0.58±0.22, 0.35±0.26, p=0.004, respectively). Congestive heart 
failure did not tend to last beyond 3 days after onset in the NTP group compared with the NC group during hospitalization (1/27 vs 4/25, odds ratio 
[OR]: 0.202, p=0.133, 95% CI: 0.021 to 1.946). At the one year follow-up, the NTP group tended to show more improvement than the NC group in 
major adverse cardiac events (5/27 vs 9/25, OR: 0.404, p=0.156, 95%CI: 0.114 to 1.437).
Conclusions: NTP is a more effective treatment for slow/no-reflow associated with PCI in patients with AMI and may improve long-term clinical 
outcomes compared with NC.
